Suresh Govatati

Suresh Govatati

Auto-generated profile, based on publicly available information

Suresh Govatati

Department of Biochemistry, Osmania University, Hyderabad, 500 007, India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2013 in Human Reproduction
Verified
Journal Article
Open access
PDF file
SGSuresh Govatati
Suresh Govatati
VKVijaya Lakshmi Kodati
Vijaya Lakshmi Kodati
MDMamata Deenadayal
Mamata Deenadayal
BCBaidyanath Chakravarty
Baidyanath Chakravarty
Sisinthy ShivajiSisinthy Shivaji
Sisinthy Shivaji
MBManjula Bhanoori
Manjula Bhanoori
Are mutations in the phosphatase and tensin homolog deleted on chromosome 10 (PTEN) gene associated with endometriosis? Loss of heterozygosity (LOH) at the 10q23.3 locus, PTEN somatic mutations and changes in the levels and distribution of proteins in the PTEN-PI3K/Akt signal transduction pathway are associated with endometriosis. Endometriosis has a strong genetic basis. Recent genome-wide association and linkage studies have reported a significant association of endometriosis with 7p15.2, 9p21 and 10q23-26 loci. PTEN, which maps to 10q23.3, acts as a tumor suppressor gene through the action of its phosphatase protein product, phosphatase and tensin homolog (PTEN). This phosphatase is involved in the regulation of the cell cycle, and mutations of PTEN are a step in the development of many cancers. A total of 1252 subjects of Indian origin (endometriosis patients = 752; controls = 500) were recruited to participate in this case–control study. Recruitment took place from 2001 to 2009 at Institute of Reproductive Medicine (IRM), Kolkata, India; Infertility Institute and Research Centre (IIRC), Secundrabad, India and Vasavi Medical and Research Centre, Hyderabad, India. LOH on 10q, 9p and 7p was analyzed in analogous ectopic–eutopic endometria along with blood samples from 32 advanced stage endometriosis patients by PCR-GeneScan analysis. Genotyping of PTEN was carried out on genomic DNA of analogous ectopic-eutopic endometria (n = 32) as well as blood samples from 720 patients and 500 controls by PCR-sequencing analysis to explore somatic and germ-line mutations, respectively. The levels and distribution of PTEN, p-Akt, p-Bad and p27 were analyzed in the eutopic endometria of patients (n = 5) and controls (n = 5) using western-blot and immunohistochemistry. PCR-GeneScan analysis revealed a higher LOH frequency at 10q23.3 (84.4%) compared with other loci analyzed, hence we focused our attention on PTEN. PCR-sequencing analysis revealed seven novel somatic mutations and 23 germ-line polymorphisms in patients. Among somatic mutations, a frame-shift insertion at 10:89692992–89692993 (in the functionally important N-terminal phosphatase domain of PTEN) occurred in 11 of the 32 ectopic endometria. Western-blot and immunohistochemical analysis revealed decreased PTEN and increased p-Akt and p-Bad levels in eutopic endometria of patients compared with controls (all comparisons, P < 0.0001). Furthermore, PTEN loss was more frequent in the nucleus than in the cytoplasm. Expression of p27 did not differ between patients and controls. Protein analysis was performed in eutopic endometrial samples from only a small number of patients and controls. In future investigations, a larger sample size should be used and the role of the other genes involved in the PTEN-PI3K/Akt signal transduction pathway should be analyzed. Our findings revealed a possible involvement of the PTEN-PI3K/Akt-Bad axis in the pathogenesis of endometriosis, which may facilitate the discovery of suitable pathway inhibitors for disease treatment. This study was supported by grants from the Science & Engineering Research Board (SERB), India (Lr No: SR/FT/LS-188/2009) to BM. The authors have no competing interests to declare.

30 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
NTNageswara Rao Tipirisetti
Nageswara Rao Tipirisetti
SGSuresh Govatati
Suresh Govatati
PPPriyanka Pullari
Priyanka Pullari
SMSravanthi Malempati
Sravanthi Malempati
TKThupurani Murali Krishna
Thupurani Murali Krishna
VSVishnupriya Satti
Vishnupriya Satti
Mitochondrial displacement loop (D-loop) is the hot spot for mitochondrial DNA (mtDNA) alterations which influence the generation of cellular reactive oxygen species (ROS). Association of D-loop alterations with breast cancer has been reported in few ethnic groups; however none of the reports were documented from Indian subcontinent. We screened the entire mitochondrial D-loop region (1124 bp) of breast cancer patients (n = 213) and controls (n = 207) of south Indian origin by PCR-sequencing analysis. Haplotype frequencies for significant loci, the standardized disequilibrium coefficient (D′) for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software. We identified 7 novel mutations and 170 reported polymorphisms in the D-loop region of patients and/or controls. Polymorphisms were predominantly located in hypervariable region I (60%) than in II (30%) of D-loop region. The frequencies of 310‘C’ insertion (P = 0.018), T16189C (P = 0.0019) variants and 310‘C’ins/16189C (P = 0.00019) haplotype were significantly higher in cases than in controls. Furthermore, strong LD was observed between nucleotide position 310 and 16189 in controls (D′ = 0.49) as compared to patients (D′ = 0.14). Mitochondrial D-loop alterations may constitute inherent risk factors for breast cancer development. The analysis of genetic alterations in the D-loop region might help to identify patients at high risk for bad progression, thereby helping to refine therapeutic decisions in breast cancer.

1 January 2019 in Mitochondrion
Verified
Journal Article
Closed access
TRTumu Venkat Reddy
Tumu Venkat Reddy
SGSuresh Govatati
Suresh Govatati
MDMamata Deenadayal
Mamata Deenadayal
Sisinthy ShivajiSisinthy Shivaji
Sisinthy Shivaji
MBManjula Bhanoori
Manjula Bhanoori

10 October 2013 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
VTVenkat Reddy Tumu
Venkat Reddy Tumu
SGSuresh Govatati
Suresh Govatati
PGPraveen Guruvaiah
Praveen Guruvaiah
MDMamata Deenadayal
Mamata Deenadayal
Sisinthy ShivajiSisinthy Shivaji
Sisinthy Shivaji
MBManjula Bhanoori
Manjula Bhanoori

1 June 2019 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
SGSuresh Govatati
Suresh Govatati
PPPrahalathan Pichavaram
Prahalathan Pichavaram
JJJagadeesh Janjanam
Jagadeesh Janjanam
BZBaolin Zhang
Baolin Zhang
NSNikhlesh K. Singh
Nikhlesh K. Singh
GRGadiparthi N. Rao
Gadiparthi N. Rao
Objective—: IL (interleukin)-33 has been shown to play a role in endothelial dysfunction, but its role in atherosclerosis is controversial. Therefore, the purpose of this study is to examine its role in vascular wall remodeling following injury. Approach and Results—: Thrombin induced IL-33 expression in a time-dependent manner in human aortic smooth muscle cells and inhibition of its activity by its neutralizing antibody suppressed thrombin induced human aortic smooth muscle cell migration but not DNA synthesis. In exploring the mechanisms, we found that Par1 (protease-activated receptor 1), Gαq/11 (Gα protein q/11), PLCβ3 (phospholipase Cβ3), NFATc1 (nuclear factor of activated T cells), E2F1 (E2F transcription factor 1), and LMCD1 (LIM and cysteine-rich domains protein 1) are involved in thrombin-induced IL-33 expression and migration. Furthermore, we identified an NFAT-binding site at −100 nt that mediates thrombin-induced IL-33 promoter activity. Interestingly, we observed that NFATc1, E2F1, and LMCD1 bind to NFAT site in response to thrombin and found that LMCD1, while alone has no significant effect, enhanced either NFATc1 or E2F1-dependent IL-33 promoter activity. In addition, we found that guidewire injury induces IL-33 expression in SMC and its neutralizing antibodies substantially reduce SMC migration and neointimal growth in vivo. Increased expression of IL-33 was also observed in human atherosclerotic lesions as compared to arteries without any lesions. Conclusions—: The above findings reveal for the first time that thrombin-induced human aortic smooth muscle cell migration and injury-induced neointimal growth require IL-33 expression. In addition, thrombin-induced IL-33 expression requires LMCD1 enhanced combinatorial activation of NFATc1 and E2F1.

19 December 2011 in Molecular Human Reproduction
Verified
Journal Article
Open access
PDF file
SGSuresh Govatati
Suresh Govatati
NTNaveen Kumar Tangudu
Naveen Kumar Tangudu
MDMamata Deenadayal
Mamata Deenadayal
BCBaidyanath Chakravarty
Baidyanath Chakravarty
Sisinthy ShivajiSisinthy Shivaji
Sisinthy Shivaji
MBManjula Bhanoori
Manjula Bhanoori
The objective of the present study was to investigate the association between gene E-cadherin single nucleotide polymorphisms (SNPs) and risk of developing endometriosis in Indian women and to evaluate the role of E-cadherin expression in the pathophysiology of endometriosis. A genetic association study was conducted in 715 endometriosis cases and 500 controls of Indian origin. We genotyped −160 C/A, +54 C/T and −347 G/GA SNPs of gene E-cadherin by PCR-sequencing and PCR-restriction fragment length polymorphism techniques. Haplotype frequencies for multiple loci and the standardized disequilibrium coefficient (D′) for pair-wise linkage disequilibrium (LD) were assessed by Haploview Software. In addition, to better understand genetic contributions to the pathophysiology of endometriosis, the expression pattern of E-cadherin in the endometrium of women with and without endometriosis was analyzed by western blot and immunohistochemical analysis. The frequencies of −347GA/GA (P = 0.026) and −160A/A (P = 0.0019) genotypes and −347G/−160A/+54C (P = 0.007) and −347GA/−160A/+54C (P < 0.0001) haplotypes were significantly different between patients and controls. Strong LD was observed between −347G/GA and −160C/A loci (D′ = 0.64) when compared with −347G/GA and +54C/T (D′ = 0.585) or −160C/A and +54C/T (D′ = 0.05) loci in cases. Furthermore, increased membranous E-cadherin expression was observed in cases than in controls. The expression seems to be genotype dependent. In conclusion, the E-cadherin −347GA/GA and −160A/A genotypes and −347GA/−160A/+54C and −347G/−160A/+54C haplotypes may jointly modify the risk of endometriosis in Indian women. In addition, the differential expression of E-cadherin may play an important role in pathogenesis of endometriosis.